A newly published case report in BMJ Case Reports (British Medical Journal) details a rare but serious autoimmune bleeding disorder, Acquired Haemophilia A (AHA), following a COVID-19 mRNA booster jab.
The case involved a male patient who developed severe bleeding and prolonged activated partial thromboplastin time (aPTT) shortly after receiving the booster.
High-dose corticosteroids and cyclophosphamide were used to manage the condition.
Although causality remains uncertain, the temporal association has raised major concerns among researchers, prompting experts to call for further investigation.
“The temporal association certainly raises concern. While rare, this very real incident should prompt interest in further investigation.”
Additional reports have identified similar cases, including elderly patients developing AHA following Pfizer-BioNTech and Moderna “vaccinations”.
Experts say these cases highlight the need for ongoing post-vaccination surveillance and investigation into rare autoimmune complications triggered by mRNA gene therapies, marketed to the public as “COVID-19 vaccines”.
Image credit: Planet Volumes
